Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
JPMorgan Chase & Co. lowered their price objective on Coherus BioSciences from $13.00 to $11.00 and set a “neutral” rating on the stock in a research report on Monday, November 14th.
Mutual of America Capital Management LLC raised its stake in Coherus BioSciences, Inc. () by 18.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC).
Shares of Coherus BioSciences, Inc. () have been assigned a consensus recommendation of “Moderate Buy” from the seven brokerages that are currently covering the company, reports.